1. Introduction {#s0005}
===============

Since environmental waste has become a critical issue for humans, animals, and vegetation, waste management via recycling has become a priority. Waste management will help protect the environment, maintain health quality, and reduce financial burdens. Recycling utilizes wastes to achieve sustainable products, such as biomaterials. The use of waste products as biomaterials utilized in the therapeutic field has added great value to the field of waste recycling ([@b0010]). Corals ([@b0080]), cuttlefish shells ([@b0110]), bovine bone ([@b0055]), and sea snail shells ([@b0125]) are examples of materials that have been successfully reused for biomaterial synthesis. Among the widely bioavailable wastes are the eggshells, which are widely-produced in the egg industry and which represent approximately 11% of the eggs' total weight ([@b0135]). The United Nations Food and Agricultural Organization (FAO) reported that, in 2004, the United States of America produced around 600,000 tons of eggshells ([@b0095]). According to the FAO (2009), egg production worldwide in 2008 was almost 62 million tons, with China having the greatest production ([@b0090]). Therefore, the need for alternative uses of eggshells seemed beneficial. Not only does eggshell calcium provide the best natural calcium source---better than that of limestone or coral sources ([@b0070], [@b0120], [@b0140])---it is also better absorbed by the body ([@b0020]). Eggshell powder has been reported as safe for use by several European and Asian animal and human studies ([@b0120], [@b0140]).

Bone tissue damage, due to disease and/or improper healing after accidents or traumatic injuries, remains a common surgical problem. Bone grafts have been used to augment osseous defects ([@b0075]). Despite the fact that autogenous bone grafts are considered the gold standard, they suffer from limitations, including inadequacy of supply, donor site morbidity, prolonged operation time, and high cost ([@b0015]). Moreover, post-transplantation graft resorption remains a problem ([@b0165]). Alloplasts have been introduced as an alternative to autogenous grafts ([@b0015]). They are used as space fillers and scaffolds to facilitate bone formation and promote wound healing ([@b0060]). Such graft materials aim to engineer/regenerate bone. Graft materials should be bioresorbable, elicit no antigen-antibody reaction and provide a reservoir for minerals that induce formation of new bone ([@b0075]). It has become well-accepted that natural products are safer than synthetic alternatives ([@b0160]). Natural coral skeleton, composed of calcium carbonates, has been reported as an effective substitute when treating osseous defects. Coralline calcium carbonate is biocompatible, fully-resorbable and results in rapid bone formation because no surface transformation to a carbonate phase is required for the initiation of bone formation ([@b0100], [@b0140]).

Eggshell has a mineral composition similar to coral, thus providing a promising material for synthesis of calcium phosphate ceramics ([@b0070], [@b0100], [@b0140]). Eggshell is a biocompatible, bioresorbable, and osteoconductive biomaterial ([@b0045], [@b0070]). It is composed of approximately 94% calcium carbonate, 1% calcium phosphate, 4% organic matter and 1% magnesium carbonate ([@b0135]). Thus, it may act as a reservoir of raw materials needed for the biosynthesis of nanomaterials ([@b0010]). The process of eggshell calcification has attracted attention since it is the most rapid biomineralization processes known ([@b0065]). In addition, eggshell powder has a positive effect on bone metabolism ([@b0115]). Commercial over-the-counter eggshell-containing supplements to support bone mineral health are available nowadays.

Although experimentally-prepared eggshell powder has been proven successful when used as an allograft ([@b0025], [@b0040], [@b0045], [@b0140]), currently to our knowledge, no data are available on the use of commercially available oral eggshell-based supplements as bone grafts. The aim of the current study was to evaluate, both histologically and histomorphometrically, an eggshell-based supplement, Membrell's® BONEhealth Plus D~3~ & K~2~, as a natural bone graft material in New Zealand rabbits. The null hypothesis of the current study was that the use of Membrell's® BONEhealth Plus D~3~ & K~2~ as a natural bone graft material in defects in New Zealand rabbits will yield no difference in bone formation compared to the untreated defects.

2. Materials and methods {#s0010}
========================

2.1. Eggshell-based supplement {#s0015}
------------------------------

Membrell's® BONEhealth Plus D~3~ & K~2~, a commercially-available over-the-counter dietary supplement for bone health, was used in the present investigation as a natural bone graft material ([Table 1](#t0005){ref-type="table"}). Contents of each capsule were emptied, weighed and equally-divided between two prepared cavities (50 g of powder per cavity).Table 1Supplement facts provided with the Membrell's® BONEhealth Plus D~3~ & K~2~ box.Supplement Facts\
Serving size 4 CapsulesAmount per serving% DV[\*](#tblfn1){ref-type="table-fn"}Vitamin C (ascorbic acid)60 mg100%Vitamin D~3~ (cholecalciferol)800 IU200%Vitamin K~2~ (menaquinone-7)40 mcg50%Calcium (as Calcium from eggshells, ESC®)1000 mg100%Magnesium500 mg125%Zinc7.5 mg50%[^1]

2.2. Transmission electron microscopy analysis {#s0020}
----------------------------------------------

The particle size of the powder within the capsule was measured using a transmission electron microscope (TEM) at 80 kV, direct magnification of 12,000×, at accelerating voltage of 200 kV with magnetic imaging resolution of 22 Å. A weight of 0.2 g powder was added to 10 ml distilled water in a plastic tube. A drop of the suspension was placed on a 200-mesh carbon-coated copper grid and allowed to evaporate to allow sample examination.

2.3. Experimental animals and surgical technique {#s0025}
------------------------------------------------

The current study was conducted following the protocol described by [@b0145], [@b0150], [@b0155]. All animal experiments complied with the EC Directive 86/609/EEC guidelines and were approved by the Faculty of Dentistry, Cairo University Research Ethics Committee (REC \#15-12-26). The procedure was conducted at the Faculty of Medicine, Cairo University Animal House. Six adult (five-month-old) New Zealand rabbits; from an inbred colony, weighing 3.5--4.0 kg were used. All animals were anesthetized with an intramuscular injection (0.59 ml/kg) of a combination of ketamine hydrochloride (Ketanes®, Alke, Turkey) and xylazine (Rompun®, Bayer, Leverkusen, Germany). The surgery was performed under sterile conditions. A midline skin incision was made on the skull, and both the periosteum and the temporalis muscle were laterally reflected using a periosteal elevator. Two full-thickness cranial bone defects measuring 5 mm × 10 mm × 1 mm were created in the parietal bones, one defect on each side of the midline (a total of 12 defects). To outline the defect, a stainless-steel wire template was bent to the required defect size to make full-thickness holes. The holes were then connected using surgical burs, under continuous copious irrigation with sterile saline. The rabbits were randomly divided into two groups by using software available online ([www.researchrandomizer.org](http://www.researchrandomizer.org){#ir005}). Group 1 was comprised of three rabbits with six defects filled with the Membrell's® BONEhealth™ powder, where the content of one capsule (100 g) was equally divided among two defects. Group 2 included three rabbits with six defects that were left empty to serve as a negative control ([@b0005], [@b0145], [@b0150], [@b0155]). The eggshell-based supplement powder was directly loaded into the cavities prepared in Group 1 rabbits. Loading was done by means of a particulate graft applicator. All wounds were closed with interrupted 3/0 black silk sutures ([Fig. 1](#f0005){ref-type="fig"}). Postoperatively, both oxytetracycline hydrochloride and buprenorphine hydrochloride were administered daily (for 10 and 14 days, respectively). The animals were sacrificed with sodium pentobarbital two weeks after the surgery.Fig. 1Surgical procedure in the experimental rabbits showing: (A) the two bone defect beds, (B) the bone defects filled with Membrell's® BONEhealth Plus D~3~ & K~2~ and (C) the surgical wound after suturing.

2.4. Specimen preparation for microscopic examination {#s0030}
-----------------------------------------------------

Immediately after animal sacrifice, the parietal bones were dissected, fixed in 10% formalin, and decalcified in EDTA for four weeks. After decalcification, tissue blocks were processed and embedded in paraffin. Five-micron sections were cut perpendicular to the bone surface, mounted on glass slides, deparaffinized, hydrated, and stained with hematoxylin and eosin (H&E) stain for histological evaluation and histomorphometric analysis.

2.5. Measuring the area percent (%) of newly-formed bone (histomorphometric analysis) {#s0035}
-------------------------------------------------------------------------------------

The area percent (%) of the newly-formed bone was estimated by means of a Leica Qwin 500 analyzer computer system, (Leica Microsystems, Switzerland). The cursor was used to outline the areas of newly-formed bone trabeculae, where these areas became masked by a binary blue color measurable by the computer. The image analyzer was calibrated to automatically convert the measurement units (pixels) produced by the image analyzer program into actual micrometer units ([Fig. 2](#f0010){ref-type="fig"}). In both groups, the area % of newly-formed bone was estimated in ten different fields in five successive regions of the defect, where region 3 represents the center of the defect ([@b0145], [@b0150], [@b0155]), using a magnification of 200×.Fig. 2The image displayed on the monitor of the image analyzer computer system (Leica Qwin 500). The area of bone trabeculae is masked by blue binary color to be measured by the computer system.

2.6. Statistical analysis {#s0040}
-------------------------

The data obtained from computer image analysis were represented as mean values and standard deviations (SD). Statistical analysis was performed using Statistical Package for Scientific Studies \#18.0 (SPSS, Inc., Chicago, IL, USA). The unpaired *t*-test was used for statistical analysis of the differences between the groups. A value of p ≤ 0.05 was considered statistically significant.

3. Results {#s0045}
==========

3.1. Results of the transmission electron microscopy analysis {#s0050}
-------------------------------------------------------------

Transmission electron micrographs revealed that the size range of all the powder ingredients of the Membrell's® BONEhealth Plus D~3~ & K~2~ were smaller than 50 nm ([Fig. 3](#f0015){ref-type="fig"}).Fig. 3Transmission electron micrograph of the Membrell's® BONEhealth Plus D~3~ & K~2~ capsule powder revealing particles of sizes 26.82, 29.46 and 30.88 nm.

3.2. Macroscopic examination {#s0055}
----------------------------

All six rabbits remained in good health throughout the course of the experiment, with no signs of infection or post-surgical complications and were, therefore, included in the histologic and histomorphometric evaluation.

3.3. Results of the microscopic examination {#s0060}
-------------------------------------------

### 3.3.1. Control group {#s0065}

H&E-stained sections, obtained from the center of the bony defects, ([Fig. 4](#f0020){ref-type="fig"}A and B), revealed the presence of fibrous tissue and thin irregular osteoid bone (B) growing in the site. Wide fibrovascular (FM) and fatty marrow (F) areas separating the scarce newly-formed bone trabeculae were observed. Lacunae-containing osteocytes were scattered within the marrow areas. Mild chronic inflammatory cell infiltration was noted within the fibrous tissue.Fig. 4Hematoxylin and Eosin-stained photomicrographs of the control group (A: 100× and B: 400×), and the experimental group (C--E: 100× F: 200×). The letters on the photomicrographs denote the following: ^\*^**B:** osteoid bone, **FM:** fibrovascular marrow, **F:** fatty marrow, **BV:** blood vessels, **C:** collagen fibers. The yellow arrow is pointing at lacunae containing osteocytes, the black arrow at inflammatory cells and the blue arrow at osteoblasts.

### 3.3.2. Experimental group (defects filled with Membrell's® BONEhealth Plus D3 & K2) {#s0070}

The H&E-stained photomicrographs of the samples from the experimental group are shown in [Fig. 4](#f0020){ref-type="fig"}C--F. Histological sections revealed deposition of osteoid newly-formed bone trabeculae (B) starting from the defect border and growing through the defect. The trabeculae were regularly arranged, separated by narrow bone marrow spaces, and surrounded by an osteoblastic layer. Lacunae containing osteocytes were detected within the trabeculae. Organized collagen fiber bundles (C) were observed at the periphery of the defects. The newly-formed bone consisted mainly of woven bone with some more mature lamellar bone apparent. No inflammatory cell infiltrate was present. The defects were free from any graft traces.

3.4. Histomorphometric analysis {#s0075}
-------------------------------

Regions 2, 3, and 4 revealed a significantly larger mean area % of newly formed bone in the experimental group compared to those regions in the control group ([Table 2](#t0010){ref-type="table"}).Table 2Mean ± SD[\*](#tblfn2){ref-type="table-fn"} of the area % occupied by bone trabeculae in the different regions in both the control and experimental groups.GroupRegion 1Region 2Region 3 (center)Region 4Region 5Control82.3 ± 11.443.2 ± 7.121.6 ± 4.939.9 ± 5.080.4 ± 9.5Experimental81.8 ± 3.053.9 ± 4.047.4 ± 1.148.2 ± 5081.0 ± 1.4Significance of difference between groupst value0.14.216.24.50.2P value0.8845 ^ns^0.0006[\*\*](#tblfn3){ref-type="table-fn"}0.0001[\*\*](#tblfn3){ref-type="table-fn"}0.0003[\*\*](#tblfn3){ref-type="table-fn"}0.8452 ^ns^[^2][^3]

4. Discussion {#s0080}
=============

Following bone loss, osseous healing of a defect is one of the primary objectives of regenerative medicine. Bone tissue can regenerate completely, provided the space into which it has to grow is below the critical defect size. Otherwise, the use of a graft is necessary ([@b0060]). In reverting to natural graft materials, eggshell has been used as a potential bone substitute in maxillofacial reconstructive surgery ([@b0100], [@b0140]). Therefore, Membrell's® BONEhealth™ Plus D~3~ & K~2~; an eggshell-based dietary supplement indicated to preserve bone health, was investigated for use as a graft material in the present study. In addition to its calcium content, it contains vitamin D~3~ (cholecalciferol, which is necessary for calcium absorption, vitamin K~2~ to help maintain bone mineralization, and vitamin C and zinc to help maintain the structural matrix of bones in healthy individuals.

In the present study, we assessed the biocompatibility and regenerative ability of an eggshell-containing supplement as a bone graft in-vivo prior to its use in humans. Mature rabbits were selected, as they represent approximately 35% of the animals utilized in musculoskeletal research. This is partly due to the ease of their handling and their size, as well as the minimal differences between human and rabbit bone composition and density. Compared to primates and some rodents, rabbits have faster skeletal change and bone turnover ([@b0105]). Moreover, osseous defects are more actively repaired in mature rabbits than in immature rabbits ([@b0155]). The protocol that was used resulted in minimal morbidity; as evidenced by the good health of all rabbits ([@b0150]).

The rabbits were sacrificed two weeks after surgery. This time interval allowed examination of bone formation during the early stages of healing and gave a better indication of the ability of new bone to grow across the bone defects ([@b0145], [@b0150], [@b0155]). The critical-sized bone defects that were created (5 mm × 10 mm × 1 mm) were big enough to ensure that no spontaneous healing would take place without leaving a hollow in the defect site. Non-grafted defects would represent non-unions that did not heal with new bone formation within fourteen days after their creation ([@b0130]). To ensure that the periosteum did not act as a barrier during healing, no periosteum approximation was done.

After two weeks, no evident inflammation or necrotic bone tissue was observed in the defects grafted with the eggshell-based material. These results were similar to those reported by Dupoirieux, who attributed such biocompatibility findings to the calcium carbonate content being a natural component of bone ([@b0025], [@b0040]). These findings were also consistent with the results by [@b0140] who reported biocompatibility and improved bone formation with eggshell powder This may verify the manufacturer's claim, that, unlike other calcium sources, Membrell's® BONEhealth™ Plus D~3~ & K~2~ ESC® was compliant with California Prop 65 for all four heavy metals, with the full daily requirement for calcium of 1000 mg per day.

Significant levels of osteoid, newly-formed, regularly-arranged bone trabeculae were observed in the eggshell-grafted defects ([Fig. 4](#f0020){ref-type="fig"}C--F). Detection of lacunae-containing osteocytes within the trabeculae denoted bone vitality. The evident merging of woven and mature bone trabeculae indicated that the maturation process was in progress. Conversely, there was minimal bone healing across the defects of the control group, as evident in [Fig. 4](#f0020){ref-type="fig"}A and B. Therefore, the null hypothesis was rejected. [@b0045] reported that new bone formation in defect sites was observed following the use of eggshell powder of particle size 1000 µm. However, our findings did not agree with those reported by [@b0030], who reported that no bone formation took place after 15 days of filling induced bony-defects in rats with eggshell powder particles ranging from 400 to 600 µm.

In the present study, the eggshell-based powder, Membrell's® BONEhealth™ Plus D~3~ & K~2~, used to fill the induced bony defects was within the nanometer range, as revealed by the TEM micrographs ([Fig. 3](#f0015){ref-type="fig"}). Compared to the control group, significantly higher bone formation was observed in both the center and in the surrounding zones of defects in the eggshell-treated group ([Table 2](#t0010){ref-type="table"}). Since new bone forms in the space left by the resorption of the graft, the higher percentage of bone formed in the center of the eggshell-treated group defects may indicate successful graft degradation and replacement. This process is known as "creeping substitution" and takes place with successful graft materials ([@b0050]). Creeping substitution was also supported by the absence of any histologically observed residual graft material. Various particle sizes of ostrich eggshell were evaluated by [@b0035], who compared the resorption kinetics of four different eggshell powder particle sizes (50, 75, 150, and 300 µm in diameter) that were implanted in subcutaneous pouches of 30 rats. They concluded that resorption of smaller particles took place shortly after the operation, whereas the larger particles were resorbed more slowly. This was explained by the degradation hypothesis, which proposed that the particles initially undergo dissolution in the surrounding fluids and are then phagocyted when they reach a critical size (10--20 µm). Since the powder particle size in the current study was within the nano-size, pinocytosis rather than phagocytosis may have taken place, thereby accelerating the degradation process ([@b0085]). Accordingly, our findings revealed that the Membrell's® BONEhealth™ Plus D~3~ & K~2~, being nano-sized, had a rapid rate of resorption and an increased osteogenic effect. However, this may possibly impair the strength of the formed bone.

Our findings were inconsistent with the findings of [@b0045], who reported that there was a correlation between particle size, resorption rate, and osteogenic effect in terms of the amount of bone formation. They concluded that the smaller eggshell particles with rapid resorption resulted in a lower level of bone formation compared to that resulting from larger eggshell particles with relatively slower resorption rate. Therefore, further investigations are needed to evaluate the strength of the formed bone and to correlate strength with the rate of graft resorption and bone formation. These findings may be of clinical value, since such rapid bone healing may shorten the time needed for prosthetic placement following bone loss. The effects of the other constituents of the tested eggshell supplement on bone formation need to be investigated as well. Furthermore, eggshell powder should be investigated as a bioactive filler in polymeric scaffolds.

5. Conclusion {#s0085}
=============

Eggshell powder is a safe, inexpensive, bioavailable, and biodegradable material that accelerates bone healing in surgical defects and may serve as a graft in maxillofacial reconstruction.
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[^1]: The Percent Daily Value (%DV).

[^2]: Mean and standard deviation of six defects.

[^3]: Statistically significant, ns = not significant at p \< 0.05.
